These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5910365)

  • 1. Progestins in the treatment of patients with endometrial adenocarcinoma.
    Smith JP; Rutledge F; Soffar SW
    Am J Obstet Gynecol; 1966 Apr; 94(7):977-84. PubMed ID: 5910365
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of in vivo and in vitro responses of endometrial adenocarcinoma to progestins.
    Holinka CF; Deligdisch L; Deppe G; Fleming H; Namit C; de la Pena MM; Gurpide E
    Adv Exp Med Biol; 1981; 138():365-76. PubMed ID: 6211063
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progestins in combined treatment of endometrial cancer].
    Voznyĭ EK; Titova VA
    Sov Med; 1990; (9):102-7. PubMed ID: 2148437
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Vaginal cytologic evaluation as a predictive test on hormone dependency and responsiveness to progestogens of endometrial adenocarcinoma.
    Ide P; Bonte J
    Br J Cancer; 1974 Aug; 30(2):175. PubMed ID: 4419502
    [No Abstract]   [Full Text] [Related]  

  • 5. Progestins in the treatment of endometrial carcinoma.
    Anderson DG
    Surg Forum; 1965; 16():398-400. PubMed ID: 5835208
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of metastasizing carcinoma of the uterus with gestagens].
    Engeler V
    Schweiz Med Wochenschr; 1971 Dec; 101(52):1906-9. PubMed ID: 5141283
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medroxyprogesterone and endometrial adenocarcinoma].
    Serment H; Spitalier JM; Ayme Y; Degiovanni E; Bardin JP
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):93-7. PubMed ID: 5453572
    [No Abstract]   [Full Text] [Related]  

  • 8. Gestagens and endometrial carcinoma.
    Kohorn EI
    Gynecol Oncol; 1976 Dec; 4(4):398-411. PubMed ID: 1001988
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaginal cytologic evaluation as a practical link between hormone blood levels and tumor hormone dependency in exclusive medroxyprogesterone treatment of recurrent or metastatic endometrial adenocarcinoma.
    Bonte J; Decoster JM; Ide P
    Acta Cytol; 1977; 21(2):218-24. PubMed ID: 266331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of progestogen therapy with the conventional treatment of endometrial carcinoma.
    Luukkainen T; Karjalainen O
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):581-5. PubMed ID: 5510182
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination chemotherapy for advanced endometrial adenocarcinoma.
    Deppe G; Bruckner HW; Cohen CJ
    Int J Gynaecol Obstet; 1980; 18(3):168-9. PubMed ID: 6109646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliation of metastatic endometrial adenocarcinoma with dimethisterone.
    Morrison J; Blunt VA
    Aust N Z J Obstet Gynaecol; 1972 Feb; 12(1):27-9. PubMed ID: 4112032
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment with high doses of progestational agents in endometrial adenocarcinoma].
    Goisis M; Servida E; Goisis F
    Minerva Ginecol; 1976 Jan; 28(1):87-96. PubMed ID: 1256709
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S; Patton R
    Minerva Ginecol; 1981 Apr; 33(4):293-306. PubMed ID: 7243070
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytologic evaluation of exclusive medroxyprogesterone acetate treatment for vaginal recurrence of endometrial adenocarcinoma.
    Bonte J; Drochmans A; Ide P
    Acta Cytol; 1970 May; 14(5):353-6. PubMed ID: 5284269
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gestagen treatment of endometrial carcinoma].
    Seewald HJ; Böhm W
    Zentralbl Gynakol; 1974 Feb; 96(5):153-7. PubMed ID: 4133105
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormone therapy in advanced forms of carcinoma of the endometrium: analysis and prospects].
    La Vecchia C; Franceschi S; Gritti P; Valente I
    Ann Ostet Ginecol Med Perinat; 1980; 101(3):181-6. PubMed ID: 7006487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral progestogens and adenocarcinoma of the uterus. An account of 3 cases of advanced endometrial carcinoma treated with an oral progestogen.
    Phillips TJ
    J Obstet Gynaecol Br Commonw; 1966 Jun; 73(3):487-9. PubMed ID: 5947437
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormonoprophylaxis and hormonotherapy in the treatment of endometrial adenocarcinoma by means of medroxyprogesterone acetate.
    Bonte J; Decoster JM; Ide P; Billiet G
    Gynecol Oncol; 1978 Feb; 6(1):60-75. PubMed ID: 620950
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of uterine adenocarcinoma with medroxyprogesterone acetate.
    Horger EO; Williamson HO; Hester LL
    J S C Med Assoc; 1966 Jun; 62(6):217-23. PubMed ID: 5227728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.